RecruitingNCT05972343
COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients
COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients: A Prospective Observational Registry
Sponsor
Washington University School of Medicine
Enrollment
100 participants
Start Date
Jul 26, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This is a subject registry study of patients who undergo cryoablation for their breast cancer after being determined not to be surgical candidates. Data collected as part of this registry will be used to assess the safety of percutaneous ultrasound-guided cryoablation in this population as well as provide long-term follow-up of subjects who received cryoablation.
Eligibility
Min Age: 18 Years
Inclusion Criteria10
- Eligibility Criteria:
- Diagnosis of breast cancer.
- Mass must be visible on ultrasound and \> 5 mm from skin.
- Not undergoing surgery, because:
- Patient has a medical condition that would not allow sedation or general anesthesia
- Surgery is not clinically indicated due to unresectable and/or metastatic disease
- Surgery is not clinically indicated for another reason
- Patient declines surgery
- At least 18 years old.
- Able to understand and willing to sign an IRB-approved written informed consent document.
Interventions
DEVICECryoablation
Takes place at single time point.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05972343
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
NCT074780161 location